Diagnostic value of CA 15-3 antibody in detecting metastatic adenocarcinoma

Anal Quant Cytol Histol. 2004 Oct;26(5):259-62.

Abstract

Objective: To determine the diagnostic value of CA 15-3 in detecting metastatic adenocarcinoma in body fluids using PreservCyt solution (Cytyc Corp., Boxborough, Massachusetts, U.S.A.) as collection fluid.

Study design: Cytospin slides prepared from 72 cases with unequivocally benign or malignant diagnosis were studied. Of the cases studied, 34 were breast carcinomas, and 17 were benign pleural effusions. Slides were stained for CA 15-3 by using the avidin-biotin complex method. Cases were evaluated for the presence of membranous or cytoplasmic staining. The percentage of cells exhibiting strong staining was estimated for both breast carcinoma and all adenocarcinomas as a group. These results were compared with CA 15-3 staining exhibited by benign mesothelium.

Results: Ninety-one percent of the breast cancer cases studied showed a positive reaction with CA 15-3, while 6% of the benign mesothelium cases were positive (p < 0.01). The sensitivity of CA 15-3 was 91 % for breast carcinoma and 80% for all adenocarcinomas. Specificity was 94% for breast carcinoma and for all adenocarcinoma.

Conclusion: CA 15-3 is a sensitive and specific marker for diagnosing adenocarcinoma in cytologic specimens using PreservCyt solution as collection fluid.

Publication types

  • Evaluation Study

MeSH terms

  • Adenocarcinoma / diagnosis*
  • Adenocarcinoma / pathology
  • Antibodies, Neoplasm*
  • Body Fluids / cytology
  • Breast Neoplasms / diagnosis
  • Breast Neoplasms / pathology
  • Female
  • Humans
  • Immunohistochemistry
  • Male
  • Mucin-1 / analysis*
  • Mucin-1 / immunology
  • Neoplasm Metastasis / diagnosis*
  • Neoplasm Metastasis / pathology
  • Pleural Effusion, Malignant / diagnosis
  • Pleural Effusion, Malignant / pathology
  • Sensitivity and Specificity

Substances

  • Antibodies, Neoplasm
  • Mucin-1